Hvilken er prisen på Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Prisen på Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) er $4.64

Hva er markedsverdien på Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Markedsverdien på Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) er $5.17B

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) Aksjesplitter

Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.

År	Splitt	Multiplikator	Kumulativ multiplikator
Ikke nok data for de angitte datoene.

År

Splitt

Multiplikator

Kumulativ multiplikator

Ikke nok data for de angitte datoene.

Selskap	Antall aksjesplitt	Kumulativ multiplikator	Land
Intuitive Surgical, Inc. ISRG.US	3	x4	US
EssilorLuxottica S.A. EL.PA	3	x20	FR
HOYA Corporation 7741.T	0	-	JP
Becton, Dickinson and Company BDX.US	6	x20	US
Alcon Inc. ALC.SW	0	-	CH

Selskap

Antall aksjesplitt

Kumulativ multiplikator

Land